Human complement regulators: A major target for pathogenic microorganisms

Current Opinion in Immunology

Volumn 12, Issue 1, 2000, Pages 44-51

  Lindahl, Gunnar ^a   Sjöbring, Ulf ^a   Johnsson, Eskil ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CLASSICAL COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT; COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT COMPONENT C3D RECEPTOR; DECAY ACCELERATING FACTOR; MEMBRANE COFACTOR PROTEIN; PROTEIN; VIRUS RECEPTOR;

ANIMAL CELL; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; HUMAN; INFECTION; MEASLES; MEASLES VIRUS; MOUSE; NONHUMAN; PROTEIN STRUCTURE; REVIEW; TRANSGENIC MOUSE; XENOTRANSPLANTATION;

EID: 0342316481     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(99)00049-7     Document Type: Review

References (60)

1. Volanakis J.E., Frank M.M. The Human Complement System in Health and Disease. 1998;Marcel Dekker, New York.
2. Cooper N.R. Evasion of complement-mediated damage by microorganisms. Rother K., Till G.O., Hänsch G.M. The Complement System. 1998;309-322 Springer, Berlin. An excellent, recent review.
3. Fishelson Z. Complement-related proteins in pathogenic organisms. Springer Semin Immunopathol. 15:1994;345-368.
4. Liszewski M.K., Farries T.C., Lublin D.M., Rooney I.A., Atkinson J.P. Control of the complement system. Adv Immunol. 61:1996;201-283.
5. Morgan B.P., Harris C.L. Complement Regulatory Proteins. 1999;Academic Press, San Diego. This recent book provides in-depth information about all aspects of complement regulatory proteins.
6. Norman D.G., Barlow P.N., Baron M., Day A.J., Sim R.B., Campbell I.D. Three-dimensional structure of a complement control protein module in solution. J Mol Biol. 219:1991;717-725.
7. Casasnovas J.M., Larvie M., Stehle T. Crystal structure of two CD46 domains reveals an extended measles virus-binding surface. EMBO J. 18:1999;2911-2922. This paper describes the first crystal structure of SCR domains and provides important information on the interactions between CD46 and measles virus.
8. Ahearn J.M., Rosengard A.M. Complement receptors. Volanakis J.E., Frank M.M. The Human Complement System In Health And Disease. 1998;167-202 Marcel Dekker, New York.
9. Fearon D.T., Carter R.H. The CD19/CR2/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity. Annu Rev Immunol. 13:1995;127-149.
10. Carroll M.C. The role of complement and complement receptors in induction and regulation of immunity. Annu Rev Immunol. 16:1998;545-568.
11. Zipfel P.F., Jokiranta T.S., Hellwage J., Koistinen V., Meri S. The factor H protein family. Immunopharmacology. 42:1999;53-60.
12. Rowe J.A., Moulds J.M., Newbold C.I., Miller L.H. P. falciparum rosetting mediated by a parasite-variant erythrocyte membrane protein and complement-receptor 1. Nature. 388:1997;292-295.
13. Barel M., Fiandino A., Delcayre A.X., Lyamani F., Frade R. Monoclonal and anti-idiotypic anti-EBV/C3d receptor antibodies detect two binding sites, one for EBV and one for C3d on glycoprotein 140, the EBV/C3dR, expressed on human B lymphocytes. J Immunol. 141:1988;1590-1595.
14. Moore M.D., DiScipio R.G., Cooper N.R., Nemerow G.R. Hydrodynamic, electron microscopic, and ligand-binding analysis of the Epstein-Barr virus/C3dg receptor (CR2). J Biol Chem. 264:1989;20576-20582.
15. Molina H., Brenner C., Jacobi S., Gorka J., Carel J.C., Kinoshita T., Holers V.M. Analysis of Epstein-Barr virus-binding sites on complement receptor 2 (CR2/CD21) using human-mouse chimeras and peptides. At least two distinct sites are necessary for ligand-receptor interaction. J Biol Chem. 266:1991;12173-12179.
16. Molina H., Perkins S.J., Guthridge J., Gorka J., Kinoshita T., Holers V.M. Characterization of a complement receptor 2 (CR2, CD21) ligand binding site for C3. An initial model of ligand interaction with two linked short consensus repeat modules. J Immunol. 154:1995;5426-5435.
17. Nemerow G.R., Houghten R.A., Moore M.D., Cooper N.R. Identification of an epitope in the major envelope protein of Epstein-Barr virus that mediates viral binding to the B lymphocyte EBV receptor (CR2). Cell. 56:1989;369-377.
18. Diefenbach R.J., Isenman D.E. Mutation of residues in the C3dg region of human complement component C3 corresponding to a proposed binding site for complement receptor type 2 (CR2, CD21) does not abolish binding of iC3b or C3dg to CR2. J Immunol. 154:1995;2303-2320.
19. Nagar B., Jones R.G., Diefenbach R.J., Isenman D.E., Rini J.M. X-ray crystal structure of C3d: a C3 fragment and ligand for complement receptor 2. Science. 280:1998;1277-1281. The 3D structure of C3dg reported here is of great interest for analysis of the role of this protein in the adaptive immune response. Since C3dg and EBV may bind to overlapping regions in CR2, this paper is also of interest with regard to interactions between EBV and CR2.
20. Naniche D., Varior-Krishnan G., Cervoni F., Wild T.F., Rossi B., Rabourdin-Combe C., Gerlier D. Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J Virol. 67:1993;6025-6032.
21. Dörig R.E., Marcil A., Chopra A., Richardson C.D. The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell. 75:1993;295-305.
22. Manchester M., Valsamakis A., Kaufman R., Liszewski M.K., Alvarez J., Atkinson J.P., Lublin D.M., Oldstone M.B.A. Measles virus and C3 binding sites are distinct on membrane cofactor protein (CD46). Proc Natl Acad Sci USA. 92:1995;2303-2307.
23. Oldstone M.B.A., Lewicki H., Thomas D., Tishon A., Dales S., Patterson J., Manchester M., Homann D., Naniche D., Holz A. Measles virus infection in a transgenic model: virus-induced immunosuppression and central nervous system disease. Cell. 98:1999;629-640. This paper, which describes a CD46 transgenic mouse line sensitive to measles virus, represents an important breakthrough in the study of both measles virus and CD46.
24. Källström H., Liszewski M.K., Atkinson J.P., Jonsson A-B. Membrane cofactor protein (MCP or CD46) is a cellular pilus receptor for pathogenic Neisseria. Mol Microbiol. 25:1997;639-647.
25. Okada N., Liszewski M.K., Atkinson J.P., Caparon M. Membrane cofactor protein (CD46) is a keratinocyte receptor for the M protein of the group A streptococcus. Proc Natl Acad Sci USA. 92:1995;2489-2493.
26. Berkower C., Ravins M., Moses A.E., Hanski E. Expression of different group A streptococcal M proteins in an isogenic background demonstrates diversity in adherence to and invasion of eukaryotic cells. Mol Microbiol. 31:1999;1463-1475.
27. Hamann J., Vogel B., van Schijndel G.M., van Lier R.A. The seven-span transmembrane receptor CD97 has a cellular ligand (CD55, DAF). J Exp Med. 184:1996;1185-1189.
28. Evans D.J., Almond J.W. Cell receptors for picornaviruses as determinants of cell tropism and pathogenesis. Trends Microbiol. 6:1998;198-202. An excellent review, including information on the binding of picornaviruses to CD55.
29. Clarkson N.A., Kaufman R., Lublin D.M., Ward T., Pipkin P.A., Minor P.D., Evans D.J., Almond J.W. Characterization of the echovirus 7 receptor: domains of CD55 critical for virus binding. J Virol. 69:1995;5497-5501.
30. Bergelson J.M., Mohanty J.G., Crowell R.L., St John N.F., Lublin D.M., Finberg R.W. Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55). J Virol. 69:1995;1903-1906.
31. Shafren D.R., Dorahy D.J., Ingham R.A., Burns G.F., Barry R.D. Coxsackievirus A21 binds to decay-accelerating factor but requires intercellular adhesion molecule-1 for cell entry. J Virol. 71:1997;4736-4743.
32. Shafren D.R., Dorahy D.J., Thorne R.F., Kinoshita T., Barry R.D., Burns G.F. Antibody binding to individual short consensus repeats of decay-accelerating factor enhances enterovirus cell attachment and infectivity. J Immunol. 160:1998;2318-2323. This paper describes studies of two picornaviruses that bind to different regions of CD55. Antibodies to one of these regions enhance binding of virus to the other region, providing an example of interactions between SCR domains.
33. Nowicki B., Hart A., Coyne K.E., Lublin D.M., Nowicki S. Short consensus repeat-3 domain of recombinant decay-accelerating factor is recognized by Escherichia coli recombinant Dr adhesin in a model of a cell-cell interaction. J Exp Med. 178:1993;2115-2121.
34. Pham T., Kaul A., Hart A., Goluszko P., Moulds J., Nowicki S., Lublin D.M., Nowicki B.J. dra-related X adhesins of gestational pyelonephritis-associated Escherichia coli recognize SCR-3 and SCR-4 domains of recombinant decay-accelerating factor. Infect Immun. 63:1995;1663-1668.
35. Jouve M., Garcia M.I., Courcoux P., Labigne A., Gounon P., Le Bouguénec C. Adhesion to and invasion of HeLa cells by pathogenic Escherichia coli carrying the afa-3 gene cluster are mediated by the AfaE and AfaD proteins, respectively. Infect Immun. 65:1997;4082-4089.
36. Peiffer I., Servin A.L., Bernet-Camard M.F. Piracy of decay-accelerating factor (CD55) signal transduction by the diffusely adhering strain Escherichia coli C1845 promotes cytoskeletal F-actin rearrangements in cultured human intestinal INT407 cells. Infect Immun. 66:1998;4036-4042. Binding of E. coli to CD55 causes cytoskeletal rearrangements in the target cell, suggesting that the pathogen exploits a signal-transduction pathway present in the cell.
37. Sargiacomo M., Sudol M., Tang Z., Lisanti M.P. Signal transducing molecules and glycosyl-phosphatidylinositol-linked proteins form a caveolin-rich insoluble complex in MDCK cells. J Cell Biol. 122:1993;789-807.
38. Dahlbäck B. Protein S and C4b-binding protein: components involved in the regulation of the protein C anticoagulant system. Thromb Haemost. 66:1991;49-61.
39. Accardo P., Sánchez-Corral P., Criado O., García E., Rodríguez de Córdoba S. Binding of human complement component C4b-binding protein (C4BP) to Streptococcus pyogenes involves the C4b-binding site. J Immunol. 157:1996;4935-4939.
40. Blom A.M., Webb J., Villoutreix B.O., Dahlbäck B. A cluster of positively charged amino acids in the C4BP α-chain is crucial for C4b binding and factor I cofactor function. J Biol Chem. 274:1999;19237-19245.
41. Thern A., Stenberg L., Dahlbäck B., Lindahl G. Ig-binding surface proteins of Streptococcus pyogenes also bind human C4b-binding protein (C4BP), a regulatory component of the complement system. J Immunol. 154:1995;375-386.
42. + lineage. J Immunol. 160:1998;860-869.
43. Johnsson E., Thern A., Dahlbäck B., Hedén L-O., Wikström M., Lindahl G. A highly variable region in members of the streptococcal M protein family binds the human complement regulator C4BP. J Immunol. 157:1996;3021-3029.
44. Johnsson E., Berggård K., Kotarsky H., Hellwage J., Zipfel P.F., Sjöbring U., Lindahl G. Role of the hypervariable region in streptococcal M proteins: binding of a human complement inhibitor. J Immunol. 161:1998;4894-4901. This paper reports that two streptococcal M proteins have a binding site for FHL-1 in the hypervariable region. This result extends previous findings that other M proteins use the hypervariable region to bind C4BP and suggests that binding of an RCA protein may be a general property of this region.
45. Mikata S., Miyagawa S., Iwata K., Nagasawa S., Hatanaka M., Matsumoto M., Kamiike W., Matsuda H., Shirakura R., Seya T. Regulation of complement-mediated swine endothelial cell lysis by a surface-bound form of human C4b binding protein. Transplantation. 65:1998;363-368.
46. Berggård K., Johnsson E., Mooi F.R., Lindahl G. Bordetella pertussis binds the human complement regulator C4BP: role of filamentous hemagglutinin. Infect Immun. 65:1997;3638-3643.
47. Ram S., Gulati S., McQuillen D.P., Boden R., Elkins C., Pangburn M.K., Rice P.A. Interactions between Neisseria gonorrhoeae and C4b-binding protein: a molecular basis for gonococcal serum resistance. Mol Immunol Abstr. 36:1999;297.
48. Malhotra R., Ward M., Sim R.B., Bird M.I. Identification of human complement factor H as a ligand for L-selectin. Biochem J. 341:1999;61-69. The ability of FH to bind L-selectin throws new light on the function of this plasma protein and is of interest also to the study of microbial pathogenesis, since it suggests that FH-binding pathogens may exploit FH not only to escape complement attack but also to adhere to L-selectin-expressing cells.
49. Horstmann R.D., Sievertsen H.J., Knobloch J., Fischetti V.A. Antiphagocytic activity of streptococcal M protein: selective binding of complement control protein factor H. Proc Natl Acad Sci USA. 85:1988;1657-1661.
50. Sharma A.K., Pangburn M.K. Localization by site-directed mutagenesis of the site in human complement factor H that binds to Streptococcus pyogenes M protein. Infect Immun. 65:1997;484-487.
51. Kotarsky H., Hellwage J., Johnsson E., Skerka C., Svensson H.G., Lindahl G., Sjöbring U., Zipfel P.F. Identification of a domain in human factor H and factor H-like protein-1 required for the interaction with streptococcal M proteins. J Immunol. 160:1998;3349-3354.
52. Blackmore T.K., Fischetti V.A., Sadlon T.A., Ward H.M., Gordon D.L. M protein of the group A Streptococcus binds to the seventh short consensus repeat of human complement factor H. Infect Immun. 66:1998;1427-1431.
53. Hellwage J., Kühn S., Zipfel P.F. The human complement regulatory factor H-like protein-1, which represents a truncated form of factor H, displays cell-attachment activity. Biochem J. 326:1997;321-327.
54. Ram S., Sharma A.K., Simpson S.D., Gulati S., McQuillen D.P., Pangburn M.K., Rice P.A. A novel sialic acid binding site on factor H mediates serum resistance of sialylated Neisseria gonorrhoeae. J Exp Med. 187:1998;743-752. This paper provides the first clear evidence that binding of a fluid-phase complement inhibitor to a human pathogen protects against complement attack. In the interaction described here, a novel sialic acid binding site in the carboxy-terminal region of FH binds to sialylated lipo-oligosaccharide on the surface of N. gonorrhoeae, causing serum resistance.
55. Ram S., McQuillen D.P., Gulati S., Elkins C., Pangburn M.K., Rice P.A. Binding of complement factor H to loop 5 of porin protein 1A: a molecular mechanism of serum resistance of nonsialylated Neisseria gonorrhoeae. J Exp Med. 188:1998;671-680. Previous evidence that FH can protect N. gonorrhoeae against complement attack by binding to sialylated lipo-oligosaccharide is extended to nonsialylated strains. Interestingly, these strains bind FH to another surface structure, a porin protein.
56. Neeleman C., Geelen S.P.M., Aerts P.C., Daha M.R., Mollnes T.E., Roord J.J., Posthuma G., van Dijk H., Fleer A. Resistance to both complement activation and phagocytosis in type 3 pneumococci is mediated by the binding of complement regulatory protein factor H. Infect Immun. 67:1999;4517-4524.
57. Stoiber H., Schneider R., Janatova J., Dierich M.P. Human complement proteins C3b, C4b, factor H and properdin react with specific sites in gp120 and gp41, the envelope proteins of HIV-1. Immunobiology. 193:1995;98-113.
58. Stoiber H., Clivio A., Dierich M.P. Role of complement in HIV infection. Annu Rev Immunol. 15:1997;649-674.
59. Weiss R.A. Xenografts and retroviruses. Science. 285:1999;1221-1222.
60. Santoro F., Kennedy P.E., Locatelli G., Malnati M.S., Berger E.A., Lusso P. CD46 is a cellular receptor for human herpesvirus 6. Cell. 99:1999;817-827.